State of Wyoming Takes $357,000 Position in The Clorox Company $CLX
The State of Wyoming has acquired a new position in The Clorox Company (NYSE:CLX), purchasing 2,427 shares valued at approximately $357,000 during the first quarter. Other institutional investors have also increased their stakes in Clorox. Analysts have mixed ratings on the stock, with a consensus rating of "Reduce" and a price target of $143.36. Clorox recently reported better-than-expected earnings and increased its quarterly dividend to $1.24, reflecting a 4.2% yield. The company's market cap stands at $14.46 billion, with a PE ratio of 18.13.
State of Wyoming purchased a new position in The Clorox Company (NYSE:CLX - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,427 shares of the company's stock, valued at approximately $357,000.
- 3 Dividend Stocks Raising Payouts—and Backing It Up With Results
Several other hedge funds also recently bought and sold shares of CLX. Wood Tarver Financial Group LLC bought a new position in Clorox in the 4th quarter valued at $31,000. GW&K Investment Management LLC raised its position in shares of Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock worth $43,000 after buying an additional 208 shares in the last quarter. Roble Belko & Company Inc boosted its stake in Clorox by 140.7% during the first quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after buying an additional 211 shares during the period. Menard Financial Group LLC bought a new stake in Clorox during the fourth quarter valued at $63,000. Finally, IMA Advisory Services Inc. purchased a new position in Clorox during the first quarter worth about $58,000. Hedge funds and other institutional investors own 78.53% of the company's stock.
Wall Street Analyst Weigh In
A number of brokerages have recently issued reports on CLX. Citigroup reiterated a "neutral" rating and set a $135.00 price target (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. JPMorgan Chase & Co. lowered their target price on shares of Clorox from $144.00 to $140.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Evercore ISI set a $140.00 target price on shares of Clorox and gave the company an "underperform" rating in a research report on Tuesday, May 6th. Jefferies Financial Group decreased their price target on shares of Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a report on Thursday, June 26th. Finally, Morgan Stanley lowered their price objective on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have given a Hold rating and three have assigned a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Reduce" and a consensus price target of $143.36.
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Get Our Latest Analysis on CLX
Clorox Trading Up 0.2%
CLX stock opened at $118.21 on Monday. The company has a market capitalization of $14.46 billion, a PE ratio of 18.13, a price-to-earnings-growth ratio of 0.94 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The Clorox Company has a one year low of $116.53 and a one year high of $171.37. The company's 50 day moving average price is $123.93 and its two-hundred day moving average price is $134.16.
- 2 High-Yield Consumer Staples Stocks Ready to Deliver Big Returns
Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating the consensus estimate of $2.24 by $0.63. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm's quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th were issued a $1.24 dividend. This is an increase from Clorox's previous quarterly dividend of $1.22. This represents a $4.96 annualized dividend and a dividend yield of 4.2%. The ex-dividend date was Wednesday, August 13th. Clorox's dividend payout ratio (DPR) is presently 76.07%.
Clorox Profile
(Free Report)The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Investing In Automotive Stocks
- Auto Tariffs Are Coming Down: 3 Stocks to Benefit Soon
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Tencent Music Stock Outshines Spotify as China’s Music Giant
- Investing In Preferred Stock vs. Common Stock
- DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Clorox Right Now?
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
